List of Tables
Table 1. Global Viral Vector and Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Viral Vector and Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Viral Vector and Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Viral Vector and Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Viral Vector and Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Viral Vector and Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Viral Vector and Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Viral Vector and Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Viral Vector and Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Viral Vector and Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Viral Vector and Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Viral Vector and Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Viral Vector and Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Viral Vector and Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Viral Vector and Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Viral Vector and Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Viral Vector and Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Viral Vector and Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Viral Vector and Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Viral Vector and Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Viral Vector and Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Viral Vector and Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Viral Vector and Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Viral Vector and Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Viral Vector and Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Viral Vector and Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Viral Vector and Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Viral Vector and Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Viral Vector and Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Viral Vector and Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Viral Vector and Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Viral Vector and Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Viral Vector and Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Viral Vector and Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Viral Vector and Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Viral Vector and Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Viral Vector and Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Viral Vector and Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Viral Vector and Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Viral Vector and Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Viral Vector and Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Viral Vector and Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Viral Vector and Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Viral Vector and Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Viral Vector and Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Viral Vector and Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Viral Vector and Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Viral Vector and Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Viral Vector and Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Viral Vector and Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Viral Vector and Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Viral Vector and Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Viral Vector and Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Viral Vector and Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Viral Vector and Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Viral Vector and Vaccine Price (US$/Unit) by Type (2020-2025)
Table 59. Global Viral Vector and Vaccine Price (US$/Unit) by Type (2026-2031)
Table 60. Global Viral Vector and Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Viral Vector and Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Viral Vector and Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Viral Vector and Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Viral Vector and Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Viral Vector and Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Viral Vector and Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Viral Vector and Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Viral Vector and Vaccine Price (US$/Unit) by Application (2020-2025)
Table 69. Global Viral Vector and Vaccine Price (US$/Unit) by Application (2026-2031)
Table 70. ABL Company Information
Table 71. ABL Description and Business Overview
Table 72. ABL Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. ABL Viral Vector and Vaccine Product
Table 74. ABL Recent Developments/Updates
Table 75. Addgene Company Information
Table 76. Addgene Description and Business Overview
Table 77. Addgene Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Addgene Viral Vector and Vaccine Product
Table 79. Addgene Recent Developments/Updates
Table 80. Aldevron Company Information
Table 81. Aldevron Description and Business Overview
Table 82. Aldevron Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Aldevron Viral Vector and Vaccine Product
Table 84. Aldevron Recent Developments/Updates
Table 85. Boehringer Ingelheim International GmbH Company Information
Table 86. Boehringer Ingelheim International GmbH Description and Business Overview
Table 87. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product
Table 89. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 90. Brammer Bio Company Information
Table 91. Brammer Bio Description and Business Overview
Table 92. Brammer Bio Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Brammer Bio Viral Vector and Vaccine Product
Table 94. Brammer Bio Recent Developments/Updates
Table 95. Charles River Laboratories Company Information
Table 96. Charles River Laboratories Description and Business Overview
Table 97. Charles River Laboratories Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Charles River Laboratories Viral Vector and Vaccine Product
Table 99. Charles River Laboratories Recent Developments/Updates
Table 100. Creative-Biogene Company Information
Table 101. Creative-Biogene Description and Business Overview
Table 102. Creative-Biogene Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Creative-Biogene Viral Vector and Vaccine Product
Table 104. Creative-Biogene Recent Developments/Updates
Table 105. Fujifilm Corporation Company Information
Table 106. Fujifilm Corporation Description and Business Overview
Table 107. Fujifilm Corporation Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Fujifilm Corporation Viral Vector and Vaccine Product
Table 109. Fujifilm Corporation Recent Developments/Updates
Table 110. General Electric Company Information
Table 111. General Electric Description and Business Overview
Table 112. General Electric Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. General Electric Viral Vector and Vaccine Product
Table 114. General Electric Recent Developments/Updates
Table 115. Waisman Biomanufacturing Company Information
Table 116. Waisman Biomanufacturing Description and Business Overview
Table 117. Waisman Biomanufacturing Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Waisman Biomanufacturing Viral Vector and Vaccine Product
Table 119. Waisman Biomanufacturing Recent Developments/Updates
Table 120. Novasep Company Information
Table 121. Novasep Description and Business Overview
Table 122. Novasep Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Novasep Viral Vector and Vaccine Product
Table 124. Novasep Recent Developments/Updates
Table 125. Pfizer Company Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Pfizer Viral Vector and Vaccine Product
Table 129. Pfizer Recent Developments/Updates
Table 130. Spark Therapeutics Company Information
Table 131. Spark Therapeutics Description and Business Overview
Table 132. Spark Therapeutics Viral Vector and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Spark Therapeutics Viral Vector and Vaccine Product
Table 134. Spark Therapeutics Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Viral Vector and Vaccine Distributors List
Table 138. Viral Vector and Vaccine Customers List
Table 139. Viral Vector and Vaccine Market Trends
Table 140. Viral Vector and Vaccine Market Drivers
Table 141. Viral Vector and Vaccine Market Challenges
Table 142. Viral Vector and Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Viral Vector and Vaccine
Figure 2. Global Viral Vector and Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral Vector and Vaccine Market Share by Type: 2024 & 2031
Figure 4. Adenovirus Product Picture
Figure 5. Fowlpox Virus Product Picture
Figure 6. Attenuated Yellow Fever Product Picture
Figure 7. Vaccinia Virus Vectors Product Picture
Figure 8. Global Viral Vector and Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Viral Vector and Vaccine Market Share by Application: 2024 & 2031
Figure 10. Research Institutes
Figure 11. Biopharmaceutical Companies
Figure 12. Others
Figure 13. Global Viral Vector and Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Viral Vector and Vaccine Market Size (2020-2031) & (US$ Million)
Figure 15. Global Viral Vector and Vaccine Sales (2020-2031) & (K Units)
Figure 16. Global Viral Vector and Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 17. Viral Vector and Vaccine Report Years Considered
Figure 18. Viral Vector and Vaccine Sales Share by Manufacturers in 2024
Figure 19. Global Viral Vector and Vaccine Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Viral Vector and Vaccine Players: Market Share by Revenue in Viral Vector and Vaccine in 2024
Figure 21. Viral Vector and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Viral Vector and Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Viral Vector and Vaccine Sales Market Share by Country (2020-2031)
Figure 24. North America Viral Vector and Vaccine Revenue Market Share by Country (2020-2031)
Figure 25. United States Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Viral Vector and Vaccine Sales Market Share by Country (2020-2031)
Figure 28. Europe Viral Vector and Vaccine Revenue Market Share by Country (2020-2031)
Figure 29. Germany Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Viral Vector and Vaccine Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Viral Vector and Vaccine Revenue Market Share by Region (2020-2031)
Figure 36. China Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Viral Vector and Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Viral Vector and Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Viral Vector and Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Viral Vector and Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Viral Vector and Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Viral Vector and Vaccine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Viral Vector and Vaccine by Type (2020-2031)
Figure 55. Global Viral Vector and Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Viral Vector and Vaccine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Viral Vector and Vaccine by Application (2020-2031)
Figure 58. Global Viral Vector and Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 59. Viral Vector and Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
